Position in CGC
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$12,308
-$5,881 QoQ
Shares Held
12,971
-18.7% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
5 quarters on record
Voting authority
Sole 97.59463418394881.ToString("F0")%
Shared 0.ToString("F0")%
None 2.4053658160511913.ToString("F0")%
Common Shares in CGC Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026STIFEL FINANCIAL CORP holds $156,487,204 across 25 Drug Manufacturers - Specialty & Generic names. CGC ranks #25 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
358,659 | $42,397,077 | |
| 2 | HLN |
Haleon plc
|
2,181,908 | $21,840,896 | |
| 3 | BCRX |
Biocryst Pharmaceuticals Inc
|
1,825,184 | $17,375,751 | |
| 4 | VTRS |
Viatris Inc
|
923,786 | $12,480,347 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
628,550 | $11,640,744 | |
| 6 | HROW |
Harrow, Inc.
|
234,660 | $8,274,111 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
316,761 | $7,580,088 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
207,595 | $6,252,760 |
All Filings in CGC
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $12,308 | 12,971 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $18,189 | 15,956 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $14,900 | 10,206 | Shares | Defined | 2025-11-12 | |
| 2024-09-30 | $73,109 | 15,168 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $101,186 | 15,688 | Shares | Defined | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||